InvestorsHub Logo
Followers 8
Posts 549
Boards Moderated 0
Alias Born 02/03/2017

Re: Cbrnlol post# 52031

Sunday, 12/29/2019 8:25:13 PM

Sunday, December 29, 2019 8:25:13 PM

Post# of 232880
Just an FYI, Leronlimab is a phase 3 primary endpoint-met molecule with zero serious AEs or resistance....
BLA submission imminent....
Manufacturing arrangements and sales already negotiated and in place.
Nice try though.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News